BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18395032)

  • 21. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
    Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
    Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental markers of twin-to-twin transfusion syndrome in diamniotic-monochorionic twins: A morphometric analysis of deep artery-to-vein anastomoses.
    De Paepe ME; Shapiro S; Greco D; Luks VL; Abellar RG; Luks CH; Luks FI
    Placenta; 2010 Apr; 31(4):269-76. PubMed ID: 20064658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology.
    Sánchez O; Llurba E; Marsal G; Domínguez C; Aulesa C; Sánchez-Durán MA; Goya MM; Alijotas-Reig J; Carreras E; Cabero L
    Hum Reprod; 2012 Feb; 27(2):358-65. PubMed ID: 22116949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
    Gu Y; Lewis DF; Wang Y
    J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of Vegfr-2 and its soluble form in preeclampsia.
    Munaut C; Lorquet S; Pequeux C; Coulon C; Le Goarant J; Chantraine F; Noël A; Goffin F; Tsatsaris V; Subtil D; Foidart JM
    PLoS One; 2012; 7(3):e33475. PubMed ID: 22428059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption.
    Tikkanen M; Stenman UH; Nuutila M; Paavonen J; Hiilesmaa V; Ylikorkala O
    Prenat Diagn; 2007 Dec; 27(12):1143-6. PubMed ID: 17960788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of post-laser fetal death in selective growth restriction complicating twin-twin transfusion syndrome using standardized definitions.
    Donepudi R; Espinoza J; Nassr AA; Belfort MA; Shamshirsaz AA; Sanz Cortes M
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):738-743. PubMed ID: 33073885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of angiogenic factors by regular and acute exercise during pregnancy.
    Weissgerber TL; Davies GA; Roberts JM
    J Appl Physiol (1985); 2010 May; 108(5):1217-23. PubMed ID: 20224004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
    Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal vascular endothelial growth factor receptor and interleukin levels in pregnant women with twin-twin transfusion syndrome.
    Anh ND; Thuong PH; Sim NT; Thao TTP; Anh LTL; Canh TTT; Dieu NV; Bac ND; Tong HV
    Int J Med Sci; 2021; 18(14):3206-3213. PubMed ID: 34400890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The placenta contributes to activation of the renin angiotensin system in twin-twin transfusion syndrome.
    Galea P; Barigye O; Wee L; Jain V; Sullivan M; Fisk NM
    Placenta; 2008 Aug; 29(8):734-42. PubMed ID: 18558429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.